Survival, durable response, and long-term safety in patients with previously treated advanced renal cell carcinoma receiving nivolumab

David F. McDermott, Toni K. Choueiri, Igor Puzanov, Stephen Hodi, Charles G. Drake, Julie R. Brahmer, Hans J. Hammers, Suzanne L. Topalian, Drew M. Pardoll, Mario Sznol, John D. Powderly, David C. Smith, Richard D. Carvajal, Jon M. Wigginton, Georgia D. Kollia, Ashok Gupta, Dan McDonald, Vindira Sankar, Jeffrey A. Sosman, Michael B. Atkins